A shared purpose: how cross-stakeholder collaboration is critical to making healthcare work.
At #FIFARMA we are getting ready for the Pharmaceutical Compliance Congress Latin America in Panama.
The event joins the most important executives regarding the development of Compliance, Ethics and Transparency Programs in the pharmaceutical industry. @CBI_Conferences.
We are FIFARMA, the Latin American Federation of Pharmaceutical Industry, a regional organization created in 1962 which represents 13 Research and Development Pharmaceutical Companies and 9 local Trade Associations across the Latin American region.
We are engaged in the development of policies that foster the access to high quality pharmaceutical innovations that prolong, preserve and improve life for patients in Latin America led by strict ethical principles focused on patients´ safety.
FIFARMA was invited by the Mexican Association of Pharmaceutical Research Industries (AMIIF) to participate in Latin America’s first Bio-Pharmaceutical Innovation Week.
The meeting, which took place in Mexico between February 6th and 8th, gathered key federal government authorities, opinion leaders, international organizations and top executives from the pharmaceutical industry and other strategic sectors.